# ERAP1

Source: https://onco.cc/targets/erap1/  
OnCo record `erap1` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

ERAP1 trims protein fragments before loading onto class I HLA. More trimming does not guarantee more useful display.

## Summary

ERAP1 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments. Trimming can produce an appropriate peptide or remove a potentially useful one; abundance of the enzyme is not a universal measure of tumour targetability. Natural display, receptor recognition and treatment benefit remain separate questions.

## Fields

- Kind: Target
- Last checked: 2026-11-09
- Symbol: ERAP1
- Class: enzyme
- Biology: ERAP1 is an endoplasmic reticulum aminopeptidase involved in shaping peptides available for class I HLA. ERAP1 and ERAP2 have complementary substrate preferences in human biochemical experiments.

## Notes

- This record describes antigen-processing biology. It does not establish an approved drug, a clinical selection threshold or a tumour-specific vulnerability.

## Sources

- UniProt Q9NZ08: reviewed human ERAP1 protein: https://www.uniprot.org/uniprotkb/Q9NZ08/entry
- Primary antigen-processing experiment (PubMed 15908954): https://pubmed.ncbi.nlm.nih.gov/15908954/
- Primary antigen-processing experiment (PubMed 12436110): https://pubmed.ncbi.nlm.nih.gov/12436110/
- HGNC ERAP1 approved gene identity: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:18173

## Connected records

- targets: [ERAP2](https://onco.cc/targets/erap2/)
- terms: [Antigen-processing machinery (APM)](https://onco.cc/terms/antigen-processing-machinery/), [HLA (human leukocyte antigen) and MHC](https://onco.cc/terms/hla/)

---
JSON: https://onco.cc/api/v1/entities/erap1.json